| COVID-19 |
1 |
1 |
| Genetics |
0 |
0.98 |
| Genomic Medicine |
0 |
0.8 |
| Europe |
0 |
0.13 |
| Human Leukocyte Antigen |
0 |
0.07 |
| Orbit |
0 |
0.07 |
| Pandemic |
0 |
0.07 |
| Thromboembolism |
0 |
0.04 |
| Antigens |
0 |
0.03 |
| Concerns of Elderly |
0 |
0.03 |
| Cytokines |
0 |
0.03 |
| Geriatrics |
0 |
0.03 |
| Heart |
0 |
0.03 |
| Hospital |
0 |
0.03 |
| Liver |
0 |
0.03 |
| Meta-Analysis |
0 |
0.03 |
| Molecular Medicine |
0 |
0.03 |
| Pharmacogenomics |
0 |
0.03 |
| Post-Acute Sequelae of SARS-CoV-2 Infection |
0 |
0.03 |
| Prognosis |
0 |
0.03 |
| Respiratory Failure |
0 |
0.03 |
| Serology |
0 |
0.03 |
| Venous Thromboembolism (VTE) |
0 |
0.03 |
| Biologic Therapy |
0 |
0.02 |
| Stem Cell Research and Therapy |
0 |
0.02 |